Shield Therapeutics Company Description

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs.

Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia.

Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.

Shield Therapeutics plc

Country	United Kingdom
Founded	2008
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	73
CEO	Anders Lundstrom

Contact Details

Address: Northern Design Centre Gateshead, NE8 3DF United Kingdom
Phone	44 1915 118 500
Website	shieldtherapeutics.com

Stock Details

Ticker Symbol	STX
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	GB00BYV81293
SIC Code	2834

Key Executives

Name	Position
Anders Lundstrom	Chief Executive Officer
Santosh Shanbhag	Chief Financial Officer